Alessandro Agosti

Generics Bullettin white paper about Olon Regulatory Affairs

 "Partner with an API manufacturer who can also navigate Regulatory Affairs"
Alessandro Agosti

Olon presents a two-year plan of investments in the Biotech Centre of Settimo Torinese

A two-year plan of investments in the Biotech Centre of Settimo Torinese to expand capacity and capability to devel...

A new high-containment production line in Olon India

Olon is delighted to announce an additional investment which will further expand its global platform for developing a...
Alessandro Agosti

Olon at European Peptide Symposium

Events 2023

In the coming months we will be present at these sector events. The list is constantly updated and may be subject to changes.


Regulatory inspections

Our facilities are regularly inspected by the most important national and foreign medicine agencies: FDA - Food and Drug Administration (USA), AIFA - Agenzia Italiana del Farmaco (Italy), AEMPS - Agencia Espanola de Medicamentos y productos sanitarios (Spain), Russian Health Authority, PEBC - Pharmacy Examining Board of Canada, COFEPRIS - Comisión Federal para la Protección contra Riesgos Sanitarios (Mexico), TGA - Therapeutic Goods Administration (Australia), PDMA - Pharmaceuticals and Medical Devices Agency (Japan), KFDA - Ministry of Food and Drug Safety (Korea), ANVISA - Agency Nacional de Vigilancia Sanitária (Brazil), WHO - World Health Organization.

2022 Rodano
2018 Settimo
2019 Garbagnate
2020 Mulazzano
2019 Dorno
2020 Segrate
2022 Casaletto
2022 Capua
2022 Derivados Quimicos
2019 Ricerca Bioscience
2022 Olon India